Stem Cell Sciences goes US
Wednesday, 04 March, 2009
Technology company Stem Cell Sciences (SCS) is to be sold to Delaware’s StemCells Inc for close to US$5 million.
SCS, which has a research laboratory in Melbourne and is headquartered in Cambridge in the UK, has an impressive portfolio of IP based around technologies for stem cell research including cell-based assays, gene delivery vehicles, cell media and methodologies.
In a statement, the companies said it was expected that SCS’s 20 full-time staff will be retained if the deal goes ahead. Agreement has already been received from 30 per cent of SCS shareholders.
An EGM to vote on the deal will be held in London on 27 March.
mRNA used to force HIV out of hiding
Using the same technology behind mRNA COVID-19 vaccines, researchers have discovered a way to...
Novel tool enables more precise gene therapy
A novel gene editor dubbed 'evoCAST' helps solve the problem of how to add long stretches...
Contact lens breakthrough lets humans see infrared light
Newly created contact lenses enable infrared vision in both humans and mice by converting...
